West Pharmaceutical Services | WST - Assets


West Pharmaceutical Services reported $4.11B in Assets for its fiscal quarter ending in March of 2026.





Assets Change Date
Align Technology USD 6.31B 80.48M Mar/2026
Avanos Medical USD 1.05B 23.6M Mar/2026
Baxter International USD 19.85B 209M Mar/2026
Becton, Dickinson and Co. USD 50.83B 4.01B Mar/2026
Cerus USD 221.86M 6.67M Dec/2025
Charles River Laboratories USD 7.73B 594.89M Mar/2026
Cooper Companies USD 12.48B 58.1M Mar/2026
Dentsply International USD 5.23B 200M Mar/2026
Haemonetics USD 2.4B 94.96M Mar/2026
ICU Medical USD 4.01B 36.74M Mar/2026
Insulet USD 2.99B 203.2M Mar/2026
Integra LifeSciences USD 3.58B 24.28M Mar/2026
IQVIA Holdings USD 29.68B 269M Mar/2026
J&J USD 200.89B 1.68B Mar/2026
Medtronic USD 91.48B 139M Dec/2025
Merit Medical Systems USD 2.72B 33.36M Mar/2026
Neogen USD 3.36B 953K Dec/2025
OraSure Technologies USD 379.17M 24M Mar/2026
Quidel USD 5.63B 140.6M Mar/2026
Repligen USD 2.93B 18.93M Mar/2026
Rockwell Medical USD 52.62M 1.34M Jun/2025
Solventum Corp USD 14.1B 197M Mar/2026
STAAR Surgical USD 451.12M 560K Mar/2026
Terumo JPY 2.31T 55.3B Mar/2026
Utah Medical Products USD 122.54M 567K Dec/2025
West Pharmaceutical Services USD 4.11B 160.2M Mar/2026